Ajanta Pharma has informed that in accordance with Regulation 42 of Listing Regulations and Regulation 9(i) of the SEBI (Buy-Back of Securities) Regulations, 2018, the Board of Directors of the Company have fixed the record date for the proposed Buy-back offer as Friday, January 14, 2022.
The above information is a part of company’s filings submitted to BSE.